4-(3-chlorophenyl)-1-((3R,5aS,6R,8aS,9R,12R,12aR)-3,6,9-trimethyldecahydro-3H-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl)-1H-1,2,3-triazole

ID: ALA5287573

Max Phase: Preclinical

Molecular Formula: C23H28ClN3O4

Molecular Weight: 445.95

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@@H]1CC[C@H]2[C@@H](C)C(n3cc(-c4cccc(Cl)c4)nn3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4

Standard InChI:  InChI=1S/C23H28ClN3O4/c1-13-7-8-18-14(2)20(27-12-19(25-26-27)15-5-4-6-16(24)11-15)28-21-23(18)17(13)9-10-22(3,29-21)30-31-23/h4-6,11-14,17-18,20-21H,7-10H2,1-3H3/t13-,14-,17+,18+,20?,21-,22-,23-/m1/s1

Standard InChI Key:  VIMUGEAEQQPVAH-XTENOKPRSA-N

Molfile:  

 
     RDKit          2D

 34 39  0  0  0  0  0  0  0  0999 V2000
    2.0263   -0.1568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3441    0.3070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2622   -1.3303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9718   -0.9755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4454   -0.2114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7631    0.2252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5896    1.6443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6072   -0.0749    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5800   -0.8664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6540   -1.4121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3909   -1.0301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9269    1.0166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4084    1.6443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4084    1.1802    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8080    0.6072    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2349    2.3811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0985    0.9892    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5000    0.5800    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    4.1823    0.1433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9172   -1.7669    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    1.2076   -2.1490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1568   -1.2484    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8936   -0.8664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4666   -1.4395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1119   -2.1763    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2932   -2.0398    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2854   -1.3030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5583   -0.5389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3770   -0.4024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8955   -1.0301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5953   -1.7942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8040   -1.9307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5800    0.5800    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1823   -2.3811    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  4  1  0
  4  1  1  0
  5  6  1  0
  6  1  1  0
  8  2  1  0
  8  9  1  0
  9  3  1  0
 10  4  1  0
 11 10  1  0
 11  5  1  0
 12  6  1  0
 13 12  1  0
  7 13  1  0
  7 14  1  6
 14 15  1  0
  1 15  1  6
  7 16  1  0
 17  7  1  0
 17  2  1  0
  6 18  1  6
  5 19  1  6
  4 20  1  6
  3 21  1  1
  9 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 22  1  0
 24 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 27  1  0
  2 33  1  1
 31 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5287573

    ---

Associated Targets(Human)

DLD-1 (17511 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SiHa (2051 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A 172 (535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

B16 (5829 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 445.95Molecular Weight (Monoisotopic): 445.1768AlogP: 4.98#Rotatable Bonds: 2
Polar Surface Area: 67.63Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 6.01CX LogD: 6.01
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.61Np Likeness Score: 1.25

References

1. Gao F, Sun Z, Kong F, Xiao J..  (2020)  Artemisinin-derived hybrids and their anticancer activity.,  188  [PMID:31945642] [10.1016/j.ejmech.2020.112044]

Source